Clinical trial
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals'…
NCT00432380 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00432380 |
|---|---|
| Title | A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants. |
| Official title | Immunogenicity and Safety of Two Doses of GlaxoSmithKline (GSK) Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Liquid Vaccine (GSK 357941A) in Healthy Infants. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infections, Rotavirus, Rotavirus Vaccines |
| Intervention type | Biological |
| Interventions | Rotarix™, Placebo |
| Enrollment | 375 |
| Start date | Mar 9, 2007 |
| Primary completion | Sep 4, 2007 |
| Completion | Sep 4, 2007 |
| First posted | Feb 7, 2007 |
| Last update posted | Jan 2, 2020 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: